Barclays’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Buy |
46,559
+17,766
| +62% | +$94.3K | ﹤0.01% | 3409 |
|
|
2025
Q1 | $234K | Sell |
28,793
-12,236
| -30% | -$99.4K | ﹤0.01% | 3251 |
|
|
2024
Q4 | $525K | Buy |
41,029
+3,526
| +9% | +$45.1K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $402K | Buy |
37,503
+28,979
| +340% | +$311K | ﹤0.01% | 3111 |
|
|
2024
Q2 | $68K | Sell |
8,524
-11,812
| -58% | -$94.2K | ﹤0.01% | 3552 |
|
|
2024
Q1 | $325K | Sell |
20,336
-14,144
| -41% | -$226K | ﹤0.01% | 3077 |
|
|
2023
Q4 | $473K | Buy |
34,480
+30,143
| +695% | +$414K | ﹤0.01% | 3030 |
|
|
2023
Q3 | $63K | Sell |
4,337
-671
| -13% | -$9.75K | ﹤0.01% | 3497 |
|
|
2023
Q2 | $85K | Buy |
+5,008
| New | +$85K | ﹤0.01% | 3457 |
|
|
2022
Q3 | – | Sell |
-90
| Closed | – | – | 4793 |
|
|
2022
Q2 | $0 | Sell |
90
-3,854
| -98% | – | ﹤0.01% | 4872 |
|
|
2022
Q1 | $34K | Buy |
+3,944
| New | +$34K | ﹤0.01% | 4146 |
|